Clinical Trial Update: Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/Phase 2 trial evaluating mycophenolate mofetil with cyclosporine to reduce graft-versus-host disease in patients undergoing donor stem cell t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Hematologic Malignancies
• Kidney Cancer

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Phase 1, Phase 2 | Status: COMPLETED